Literature DB >> 23125245

Fc gamma receptor 3a genotype in follicular lymphoma: the end of the story? Reply to "Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone". Haematologica. 2012;97(6):937-942.

Vít Procházka, Jana Gazdová, Tomás Papajík.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23125245      PMCID： PMC3487428          DOI： 10.3324/haematol.2012.071563

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  5 in total

1.  Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone.

Authors:  Daniel O Persky; David Dornan; Bryan H Goldman; Rita M Braziel; Richard I Fisher; Michael Leblanc; David G Maloney; Oliver W Press; Thomas P Miller; Lisa M Rimsza
Journal:  Haematologica       Date:  2012-01-22       Impact factor: 9.941

2.  NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas.

Authors:  Andrew D Zelenetz; Jeremy S Abramson; Ranjana H Advani; C Babis Andreadis; John C Byrd; Myron S Czuczman; Luis Fayad; Andres Forero; Martha J Glenn; Jon P Gockerman; Leo I Gordon; Nancy Lee Harris; Richard T Hoppe; Steven M Horwitz; Mark S Kaminski; Youn H Kim; Ann S Lacasce; Tariq I Mughal; Auyporn Nademanee; Pierluigi Porcu; Oliver Press; Leonard Prosnitz; Nashitha Reddy; Mitchell R Smith; Lubomir Sokol; Lode Swinnen; Julie M Vose; William G Wierda; Joachim Yahalom; Furhan Yunus
Journal:  J Natl Compr Canc Netw       Date:  2010-03       Impact factor: 11.908

3.  Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  M Dreyling; M Ghielmini; R Marcus; G Salles; U Vitolo
Journal:  Ann Oncol       Date:  2011-09       Impact factor: 32.976

4.  Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98.

Authors:  Giovanni Martinelli; Shu-Fang Hsu Schmitz; Urs Utiger; Thomas Cerny; Urs Hess; Simona Bassi; Emmie Okkinga; Roger Stupp; Rolf Stahel; Marc Heizmann; Daniel Vorobiof; Andreas Lohri; Pierre-Yves Dietrich; Emanuele Zucca; Michele Ghielmini
Journal:  J Clin Oncol       Date:  2010-08-09       Impact factor: 44.544

5.  FcγRIIIA receptor genotype does not influence an outcome in patients with follicular lymphoma treated with risk-adapted immunochemotherapy.

Authors:  V Prochazka; T Papajik; J Gazdova; M Divoka; S Rozmanova; E Faber; L Raida; L Kucerova; K Langova; M Jarosova; K Indrak
Journal:  Neoplasma       Date:  2011       Impact factor: 2.575
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.